Call for proposals 2017 - H2020 - Better health and care, economic growth and sustainable health systems H2020-SC1-BHC-2018-2020 Open!

Objectives

This call will aim at reconciling better health and healthy ageing with the need to develop sustainable health and care systems and growth opportunities for the health and care related industries. The scope of the call may range from prevention, diagnosis, stratified approaches, predictive toxicology, the development of novel and repurposed therapeutic approaches, including medical technologies and advanced therapies, cohorts and registries-based research, to integration of care and systemic digital solutions for health and ageing well. It aims to translate new knowledge into innovative applications and accelerate large-scale uptake and deployment in different health and care settings, making health and care systems and services more accessible, responsive and efficient in Europe and beyond. To this end, the inclusion of private companies and other innovators in the projects is encouraged.

Actions

This call will be implemented through five main priorities:

  • Personalised medicine
  • Innovative health and care industry
  • Infectious diseases and improving global health
  • Innovative health and care systems - Integration of care
  • Decoding the role of the environment, including climate change, for health and well-being

This call covers the following topics:

  • SC1-BHC-01-2019: Understanding causative mechanisms in co- and multimorbidities
  • SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies for complex disorders
  • SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease
  • SC1-BHC-04-2018: Rare Disease European Joint Programme Cofund
  • SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches
  • SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications
  • SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future
  • SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis
  • SC1-BHC-13-2019: Mining big data for early detection of infectious disease threats driven by climate change and other factors
  • SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases
  • SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
  • SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
  • SC1-BHC-18-2018: Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)
  • SC1-BHC-19-2019: Implementation research for maternal and child health
  • SC1-BHC-21-2018: Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation
  • SC1-BHC-22-2019: Mental health in the workplace
  • SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care
  • SC1-BHC-25-2019: Demonstration pilots for implementation of personalised medicine in healthcare
  • SC1-BHC-26-2018: HTA research to support evidence-based healthcare
  • SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals
  • SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health
  • SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine
  • SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine - a European standardization framework
  • SC1-HCO-04-2018: ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
  • SC1-HCO-05-2018: Strengthening regulatory sciences and supporting regulatory scientific advice
  • SC1-HCO-06-2018: Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats
  • SC1-HCO-08-2018: Creation of a European wide sustainable clinical research network for infectious diseases
  • SC1-HCO-09-2018: Building international efforts on population and patient cohorts
  • SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives
  • SC1-HCO-11-2018: Strategic collaboration in health research and innovation between EU and China
  • SC1-HCO-12-2018: Innovation in healthcare - a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems
  • SC1-HCO-13-2018: Setting the priorities for a European environment, climate and health research agenda

European community funding

The Community provisional funding available for the call for proposals is:

  • 949,00 Million EUR (Global Budget)

All the important deadlines

  • 06 February 2018 - 3 months ago (Deadline for the presentation of proposals)
  • 18 April 2018 - one month ago (Deadline for the presentation of proposals)
  • 04 September 2018 - in 3 months (Deadline for the presentation of proposals)
  • 02 October 2018 - in 4 months (Deadline for the presentation of proposals)
  • 16 April 2019 - in 10 months (Deadline for the presentation of proposals)

Further information about the call

Official webpage of the call

Useful documents

  • Work Programme 2018-2020 (Work programme)

Organisations eligible to participate

Opened to the following bodies or institutes with legal status established in the covered areas:

  • Any legal organisation

Covered areas

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

  • European Union (EU)

Directorate-Generale responsible

Directorate-General for Research

Related calls for proposals

Related calls

Explore other programmes